Improving the efficiency of Vγ9Vδ2 T-cell immunotherapy in cancer

T Hoeres, M Smetak, D Pretscher… - Frontiers in …, 2018 - frontiersin.org
Increasing immunological knowledge and advances in techniques lay the ground for more
efficient and broader application of immunotherapies. gamma delta (γδ) T-cells possess …

Harnessing allostery: a novel approach to drug discovery

S Lu, S Li, J Zhang - Medicinal research reviews, 2014 - Wiley Online Library
Allostery is the most direct and efficient way for regulation of biological macromolecule
function, ranging from the control of metabolic mechanisms to signal transduction pathways …

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

S Meraviglia, M Eberl, D Vermijlen… - Clinical & …, 2010 - academic.oup.com
The potent anti-tumour activities of γδ T cells have prompted the development of protocols in
which γδ-agonists are administered to cancer patients. Encouraging results from small …

Antiresorptives and osteonecrosis of the jaw

J Yamashita, LK McCauley - Journal of Evidence Based Dental Practice, 2012 - Elsevier
Osteonecrosis of the jaw (ONJ) is an uncommon condition noted to occur in patients who are
receiving osteoclast-targeted antiresorptive therapy. The incidence of ONJ in patients taking …

Anti‐tumour immunotherapy with V γ9 V δ2 T lymphocytes: from the bench to the bedside

MS Braza, B Klein - British journal of haematology, 2013 - Wiley Online Library
Gamma delta (γδ) Τ cells are non‐conventional T lymphocyte effectors that can interact with
and eradicate tumour cells. Several data demonstrate that these T cells, which are …

Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism

H Wang, G Sarikonda, KJ Puan, Y Tanaka… - The Journal of …, 2011 - journals.aai.org
Human Vγ2Vδ2 T cells monitor isoprenoid metabolism by recognizing (E)-4-hydroxy-3-
methyl-but-2-enyl pyrophosphate (HMBPP), an intermediate in the 2-C-methyl-d-erythritol-4 …

Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery

W Jahnke, JM Rondeau, S Cotesta, A Marzinzik… - Nature chemical …, 2010 - nature.com
Bisphosphonates are potent inhibitors of farnesyl pyrophosphate synthase (FPPS) and are
highly efficacious in the treatment of bone diseases such as osteoporosis, Paget's disease …

Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers

DD Waller, J Park, YS Tsantrizos - Critical reviews in biochemistry …, 2019 - Taylor & Francis
Dysregulation of isoprenoid biosynthesis is implicated in numerous biochemical disorders
that play a role in the onset and/or progression of age-related diseases, such as …

Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis

LT Duong, GA Wesolowski, P Leung, R Oballa… - Molecular cancer …, 2014 - AACR
Cathepsin K (CatK) is essential for osteoclast-mediated bone resorption. CatK expression is
also detected in breast cancer cells that metastasize to bone. Here, the CatK inhibitor L-235 …

A Facile Cu(I)/TF-BiphamPhos-Catalyzed Asymmetric Approach to Unnatural α-Amino Acid Derivatives Containing gem-Bisphosphonates

ZY Xue, QH Li, HY Tao, CJ Wang - Journal of the American …, 2011 - ACS Publications
A novel catalytic asymmetric Michael addition of azomethine ylide with β-substituted
alkylidene bisphosphates was realized in the presence of a chiral copper (I)/TF-BiphamPhos …